Digital Health in a Mobile World
Healthcare is shaping up to be an important area for all the big technology companies that focus on mobile devices. And that is pretty much all of them. When Sony sold off its VAIO computer division to...
View ArticleNIH, Patients and Industry Ramp Up to AMP-lify Innovation
Speakers at Wednesday’s BIO 2014 Super Session – AMP-lifying Innovation: NIH, Patient Organizations & Leading Biopharma Firms Mobilize to Tackle Tough Diseases – discussed the new Accelerating...
View Article21st Century Cures: Accelerating the Discovery-Development-Delivery Cycle
How can we give patients faster access to innovative treatments and cures? That’s the question the House Energy and Commerce Committee is asking our nation’s foremost medical experts and innovators...
View ArticleMaking the Case for Personalized Medicine
Personalized medicine is the customization of healthcare. Already, a suite of molecular approaches is being used to tailor certain medical decisions, practice and products to the individual patient....
View ArticleNew Target for Alzheimer’s Disease
Biotechnologists have developed a drug candidate that blocks production of diseasecausing neurotoxins in mouse models Reducing the concentration of cathepsin B using an enzyme inhibitor prevents the...
View ArticleA Better Way to Make Unnatural Amino Acids Discovered by Yu
Certain amino acids that are not found in nature are highly sought after by pharmaceutical manufacturers. These “unnatural” amino acids have traditionally been very difficult to synthesize, so a new...
View ArticleSeeing is Believing
PET and MRI imaging helps companies to make go/no go decisions earlier Attrition or failure of new drug programs is a major source of concern, with failure rates ranging from 75 percent in...
View ArticleAccess to Big Data
Aquiring information rapidly and reliably reduces costs and advances discovery Sixty years ago, when James Watson and Francis Crick elucidated and published their seminal work on the double helical...
View ArticleExchange Plans are Helping Patients, But Challenges Remain
After describing many of the benefits the Exchanges have brought to patients—including access to both coverage and federal subsidies—the moderator for the 2014 BIO International Convention breakout...
View ArticleIs Regulatory Transformation for Alzheimer’s Therapies Needed?
BIO 2014′s session titled ” Regulatory Transformation: As Alzheimer’s Disease Science, Research and Advocacy Move Toward Earlier Detection and Intervention, How Will Researchers Adapt to this...
View Article
